Global Cancer Registry Software Market By Software Type (Standalone, Integrated) By Database (Public Data, Commercial Data) By Deployment Model (Cloud-Based, On-Premise) By Functionality (Cancer Reporting, Patient Care, Product Outcome Evaluation, Medical Research) By End-Users (Hospital & Medical Practice, Pharma Biotech & Medical Device Companies, Government & Third Party, Research Centers, Private Payers, and Other End-Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Report Overview

In 2022, the Global Cancer Registry Software Market was valued at USD 73.4 Million and is expected to grow to around USD 194.3 Million in 2032. Between 2023 and 2032, this market is estimated to register the highest CAGR of 10.5%.

A cancer registry is described as a database that organizes, collects, and saves data on patients suffering from cancer in order to assess conditions, cancer-specific outcomes, and drug or medical device exposure. Cancer patient registration software is a program that aids cancer registries by storing, controlling, and providing access to cancer-specific information.

By Software Type Analysis

Based on software type, the market is segmented into standalone software and integrated software. Integrated software is the lucrative segment of the cancer registry software market due to evolving nature of the market, and the need to improve workflows, optimize processes, and moderate physician workloads.

Factors that fuel market growth are the government’s increased emphasis on population health management, coordinated care, and healthcare expenses. Automated features of standalone software in reducing IT overhead costs. CAN REG 5 is a standalone software introduced by WHO that is open- source features like automated system backup and data restoration. Integrated software is anticipated to show significant growth over the forecast period owing to the rising need for integrating software with a regional oncology network.

This will help in tracking affected geographic locations and assess the clinical intervention. In the future, this will help in gaining information on disease burden and the effectiveness of treatment programs. Combination with screening archives is also a need to identify screen-detected cancers and enhance evaluation techniques. These factors are expected to propel the market growth during the forecast period.

By Database Analysis

Based on the database, the cancer registry software market is segmented into public and commercial data. The commercial database segment is expected to be the most lucrative segment of the cancer registry software market. This is because it has more data privacy than the public data sector. The governmental coding requirements are followed by the commercial database. It provides clear and well-organized information. Commercial technologies promote data transmission between government research agencies like CDC and central cancer registries.

By Deployment Model Analysis

Based on deployment model analysis, the cancer registry software market is segmented into cloud- and on-premise. The on-premise segment holds the majority of the market. Adoption by hospitals and research institutes of on-premise solutions is increasing due to benefits like less risk of external attacks and high data security against breaches boosting the market. They are helpful in Heavy data file transfers and system upgrades. On-premise models are mostly used by research institutes due to the confidentiality of data and the advanced features of these models.

The cloud-based segment is expected to grow during the forecast period due to its low installment charges and overhead IT costs. It provides a service solution platform. The advantages of cloud-based systems are real-time data analysis and integration by standard guidelines. The data safety of the model is being examined, which will soon propel market growth.

By Functionality Analysis

Based on functionality, the cancer registry software market is segmented into cancer reporting, patient care, product outcome evaluation, and medical research. The patient care management segment has the most market share. It provides various medical services that assist people in keeping a record of their health, ranging from primary care appointment scheduling to short-term case management and chronic illness management. Product quality evaluation to characterize its experience and serve as a future design source. Many items are reviewed utilizing user experience approaches and procedures.

By End-User Analysis

Based on end-user, the market for cancer registry software is segmented into hospital & medical practice, pharma biotech & medical device companies, government & third party, research centers, private payers, and other end-users. The government and third parties held the largest revenue share of the cancer registry software market. To reduce the cancer burden in developed and developing countries, the government has increased the implementation of this software to fuel market growth. Most affected areas are tracked easily, so the government can take preventive measures.

An increase in government funding in hospitals for software implementation boosts the segment. The research institutes segment is also the fastest-growing segment during the forecast period. This is because of the rise in research initiatives undertaken by government and private organizations to address the rising cancer incidence. To track patients for clinical trials and check the efficacy of treatment programs software is used by institutes. The pharmaceutical, biotechnology, and medical devices companies segment is also expected to show significant growth during the forecast period due to rising R&D by these companies for better treatment outcomes.

Key Market Segments

Based on Software Type

• Standalone
• Integrated

By Database

• Public Data
• Commercial Data

By Deployment Model

• Cloud-Based
• On-Premise

By Functionality

• Cancer Reporting
• Patient Care
• Product Outcome Evaluation
• Medical Research

By End-User

• Hospital & Medical Practice
• Pharma Biotech & Medical Device Companies
• Government & Third Party
• Research Centers
• Private Payers
• Other End-Users

Driving Factors

Growing incidence of cancer globally

The rising cancer incidence is one of the key factors driving the market growth. The cancer registry software is helpful in tracking and monitoring patients’ health suffering from cancer. This data collected from the software guides researchers, and healthcare practitioners to develop therapeutics for cancer treatment.

Growing Geriatric Population

The growing geriatric population is another key factor driving the market growth over the forecast period. The data obtained from this software helps control the spread of cancer globally. It is also useful in tracking patients in particular locations and regions. This contributes to the growth of the market.

Adoption of advanced technology

The adoption of advanced technology is another factor surging the growth of the cancer registry software market. Electronic health records are helpful for tracking data. Hence this software is adopted on a large scale across all healthcare and research centers. The developed and developing countries’ governments’ efforts are likely to contribute to the market growth during the forecast period.

Restraining Factors

Risk factors related to privacy and data security-related concerns

Health data from cancer patient databases or registries include a variety of demographic and personal factors, such as marital status, socioeconomic status, mental and/or emotional stability, physical abilities, age, gender, and race. In general, health information contains details on the patient and their family. Patient information may therefore be exposed in circumstances like data breaches.

About 30% of data breaches in the healthcare industry result in medical identity theft. Often, it is due to a lack of internal patient information control, top management support, outdated rules and procedures, non-adherence to existing ones, and inadequate staff training. The twin needs of privacy and several administrations are addressing information freedom.

Opportunity

Rising number of accountable care organizations

Accountable Care Organizations (ACOs) work to provide coordinated care and effective chronic disease management. Payments of these organizations sum with the achievement of their healthcare quality goals and outcomes that result in cost savings for the medical care delivery system. To increase patient care, ACOs must know their population, providers, patients, and the state of care. Powerful tools that support ACOs and other organizations taking part in accountable care arrangements are cancer patient registries focusing on specific populations and adapting to changing requirements.

Trends

The cancer registry software trend having a positive impact is the increasing clinical research for oncology. Clinical trials to develop novel approaches for cancer treatment are conducted by pharmaceutical and research institutes. Identification of proper monitoring of cancer causes and cures are identified by clinical trials and in-depth analyses of registry data during clinical research.  During phase III and IV clinical trials, research institutes and pharmaceutical companies use cancer registries as a follow-up source. The data quality of public and private cancer registry organizations is improved by developing advanced cancer registry software. This contributes to market growth.

COVID-19 Impact Analysis

COVID-19 had a negative impact on the cancer registry software market

Due to the COVID-19 pandemic, there was a considerable decrease in cancer diagnoses because chemotherapy, surgery and other cancer treatments were postponed. Also, doctors had to postpone post-endoscopic resection, surgical resection of cancer, and post-polypectomy cancer. Because of the high risk of infection, cancer patients’ screening was also postponed, which resulted in a decrease in treatment operations. Along with a move towards electronic reporting systems, the government is committed to funding future registry operations as a disease control asset to secure the global sustainability of cancer surveillance.

Regional Analysis

North America holds the dominating regional share of the cancer registry software market. Tobacco smoking and lack of physical activity are some factors responsible for rising cancer cases and propelling market growth. Also, factors like the presence of key industry players, increase in investments in healthcare IT, and high adoption of software fuel market growth. Asia Pacific is expected to be the fastest growing during the forecast period.

This is because of the increase in initiatives taken by the governments in this region. To improve existing healthcare infrastructure, initiatives are taken in Japan by the Ministry of Health, Labour, and Welfare in Japan. Also, pharmaceutical companies’ shift to low-cost manufacturing countries like China and India further propel the market growth in this region.

Key Regions and Countries

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

The developing important companies are concentrating on a number of strategic policies in order to expand their separate operations in overseas markets. Several cancer registry software market organizations focus on growing their operations and research and development, businesses in this market are developing new products and portfolio expansion strategies through investments, mergers, and acquisitions. Several main companies are now focused on various marketing methods, such as promoting health awareness, which is encouraging market growth.

Market Key Players

The cancer registry software industry is fragmented due to numerous local and regional companies. Market participants face tremendous rivalry from top market participants, particularly those with extensive distribution and strong brand recognition. Companies have gained various expansion strategies, such as partnerships and product launches, to improve their presence in the market.

• Rocky Mountain Cancer Data Systems
• McKesson Corporation
• Onco Inc.
• Elekta AB
• IBM Corporation
• C/Net Solutions
• Ordinal Data Inc.
• Himagine Solutions Inc.
• Electronic Registry Systems Inc.
• CONDUENT Inc.
• Other Key players

Recent Developments

• In May 2022: Roche and Kaiku Health entered into a strategic partnership in digital patient monitoring and management (DPMM). Roche and Kaiku Health focus on deploying digital tools to provide real-time symptom management by patients and Health Care Providers (HCPs), improve patient support, and provide personalized cancer care to cancer clinics and patients globally.
• In March 2022: Elekta said that the NHSSC had ordered numerous licenses for its ProKnow software system, which centralizes and analyzes radiotherapy data on a secure, scalable platform available to all NHS England radiation oncology facilities nationwide.

Report Scope: